Axsome Therapeutics, Inc. | Company Profile - Revenue, Headcount, Tech Stack, Contacts

Axsome Therapeutics, Inc. | Company Profile - Revenue, Headcount, Tech Stack, Contacts

Updated February 13, 2026
Public ProfileLinkedInLinkedIn Profile

Axsome Therapeutics, Inc.

Employees208
Revenue$385.7M
Market Cap9.3B

Industry & Market

Primary Industry
research
All Industries
researchbiotechnology
Location
New York, New York, United States
Public Trading
NASDAQ: AXSM

Funding Information

Annual Revenue
$385,693,000
Publicly traded company

Headcount Distribution

Total Employees
208
Departments
19

By Department

Department Breakdown

Business Development
Marketing
Operations
Sales
Finance
Product Management
Others

Keywords & Focus Areas

biopharmaceuticalspaincnsnarcolepsymajor depressive disorderalzheimers disease agitationfibromyalgiasmoking cessationmigraineattention deficit hyperactivity disorderbiotechnologylife sciencesbiotechnology: pharmaceutical preparationshealth carebiotechnology researchrevenue growthregulatory strategytherapeutic innovationpharmaceutical and medicine manufacturingdrug repurposing+10 more
30 total keywords

Overview

Axsome Therapeutics, Inc. is a biopharmaceutical company based in New York, founded in January 2012 by Dr. Herriot Tabuteau, Chairman and CEO. The organization specializes in developing and commercializing innovative therapies for central nervous system (CNS) disorders with limited treatment options. Axsome advances drug candidates through clinical trials and regulatory approvals to address unmet needs in the CNS landscape.

The company has reached significant milestones, including its initial public offering in 2015, positive Phase 3 results for AXS-05 in 2019, and the FDA approval of Auvelity™ in 2022 for major depressive disorder. In 2023, Axsome launched Auvelity™, generating $130.1 million in net product revenue, along with $65.7 million from its Sunosi product. Ongoing development efforts target a wide range of CNS conditions.

Key Metrics

Total Employees
XXXX
Total number of employees
Engineering
XX
Number of employees in the engineering department
Sales Team
$XX
Number of employees in the sales department
Marketing
XX
Number of employees in the marketing department
Founded
XXXX
Year the company was founded
Revenue
$XXX,XXX,XXX
Total revenue of the company
Total Funding
$XXX M
Total funding of the company
Market Cap
$XXX,XXX
Market cap of the company

Get Complete Company Metrics

Dive deeper into employee structure, funding, revenue, and key performance indicators all in one place.

Start For Free

Contact

Company
Axsome Therapeutics, Inc.
Headquarters
One World Trade Center, New York, NY 10007, US
Founded
2012
Languages
English
Industry
research

Technology Stack

Analytics & Tracking

Google Tag Manager

Social & Marketing

Not found

Database & Backend

Not found

Cloud & Infrastructure

CloudFlare HostingCloudflare DNS

Productivity

Not found

Compare similar companies to Axsome Therapeutics, Inc.

Compare insights from companies similar to Axsome Therapeutics, Inc., focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company NameRevenueNo. of EmployeesTypeFundingFounded InTop Executive
xxxxxxxx
$76476108Private-103
xxxxxxxx
xxx
$1035036Private-5279
xxxxxxxxxx
xxxxxxx
$5364151Private-7487
xxxxx
xxxxxx
$75699112Private-2451
xxxx
xxx
$711844Private-9185
xxxx

Discover Similar Companies Instantly

Explore detailed insights and analysis on companies related to your search.

Start For Free

Turn this profile into a pipeline

Find decision makers, more insights and contact information about this company on Bitscale

Start For Free

Schedule your demo now!

See how BitScale can supercharge your outbound sales in a 30-minute demo

Start for Free

Resources

Careers

Pricing

homeCommunity

Security

SayData

© 2026 Bitscale. Featherflow Technology Pvt Ltd.

LinkedInTwitterInstagramYouTube
AICPAGDPR
CCPAISO
LinkedInTwitterInstagramYouTube